Incentivizing Directors Through Stock Options
First written in FY2018. 1 of 4 entries say "Restated". Latest entry: FY2024-Q1.
1 other company's latest entry also says "Dropped".
- FY2024-Q1DroppedAnnual report
「Gain on reversal of share acquisition rights - ¥34.911 million」
For the first quarter, the status of shares and other instruments states that there were no applicable stock acquisition rights or similar instruments, while ¥34.911 million in income from the reversal of stock acquisition rights was recorded on the income statement. No disclosure of the balance or exercise of the stock acquisition rights previously disclosed for directors could be confirmed. - FY2021AdvancedAnnual report
「Before vesting (shares) End of previous fiscal year 130,000 Granted － Forfeited － Vested 130,000 Unvested － After vesting (shares) End of previous fiscal year － Vested 130,000 Exercised － Forfeited － Outstanding and unexercised 130,000」
The 130,000 shares underlying the stock options for directors vested, and none have yet been exercised. - FY2019RestatedAnnual report
「Number of shares underlying the stock acquisition rights: 130,000 (Note 1) / Exercise period for the stock acquisition rights: 12 July 2020 to 11 July 2028」
Stock options for directors were established for 130,000 shares, with the exercise period also continuing to be disclosed. - FY2018First statedAnnual report
「Pursuant to the Companies Act, at the annual general meeting of shareholders held on 25 May 2018, the company passed a special resolution to allot stock acquisition rights to its directors as stock options on particularly favorable terms and to delegate to the Board of Directors the authority to determine the offering terms of those stock acquisition rights.」
The company has approved a stock option plan for directors as an incentive to improve performance and increase corporate value, capped at 1,500 rights, 150,000 underlying shares and annual compensation of ¥20 million.